HIV-1 iglb12 neutralizing VRC-01 antibody-stimulating anti-CD4 vaccine (Fred Hutchinson)

N/A

Report date: 2025/03/20 15:42:38

Base Information

Drug NameHIV-1 iglb12 neutralizing VRC-01 antibody-stimulating anti-CD4 vaccine (Fred Hutchinson)
Drug Alias NameN/A
ClassificationVaccinesBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionT-cell surface antigen CD4 modulators
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFred Hutchinson Cancer Research Center
China Registration ClassN/A

Develop Information

Active CompaniesFred Hutchinson Cancer Research Center
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A